TEST BANK
Pathophysiology 7th Edition
Jacquelyn L. Banasik - ISBN: 9780323761550
5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v
,Chapter5v01:5vIntroduction5vto5vPathophysiology
Banasik:5vPathophysiology,5v7th5vEdition5v
MULTIPLE5vCHOICE
1. C.Q.5vwas5vrecently5vexposed5vto5vgroup5vA5vhemolytic5vStreptococcus5vand5vsubsequently5vdev
eloped5va5vpharyngeal5vinfection.5vHis5vclinic5vexamination5vreveals5van5voral5vtemperature5vof5v102.35vF,5v
skin5vrash,5vdysphagia,5vand5vreddened5vthroat5vmucosa5vwith5vmultiple5vpustules.5vHe5vcomplains5vof5vs
ore5vthroat,5vmalaise,5vand5vjoint5vstiffness.5vA5vthroat5vculture5vis5vpositive5vfor5vStreptococcus,5vand5vant
ibiotics5vhave5vbeen5vprescribed.
The5vetiology5vof5vC.Q.’s5vdisease5vis
a. a5vsore5vthroat.
b. streptococcal5vinfection.
c. genetic5vsusceptibility.
d. pharyngitis.
ANS:5vB
Etiology5vrefers5vto5vthe5vproposed5vcause5vor5vcauses5vof5va5vparticular5vdisease5vprocess.5vA5vsore5vthr
oat5vis5vthe5vmanifestation5vof5vthe5vdisease5vprocess.5vGenetic5vsusceptibility5vrefers5vto5vinherited5vte
ndency5vto5vdevelop5va5vdisease.5vPharyngitis5vrefers5vto5vinflammation5vof5vthe5vthroat5vand5vis5valso5va5v
clinical5vmanifestation5vof5vthe5vdisease5vprocess.
2. A5v17-year-old5vcollege-
bound5vstudent5vreceives5va5vvaccine5vagainst5van5vorganism5vthat5vcauses5vmeningitis.5vThis5vis5van
5vexample5vof
a. primary5vprevention.
b. secondary5vprevention.
c. tertiary5vprevention.
d. disease5vtreatmen
t.5vANS:5vA
NURSINGTB.COM
Primary5vprevention5vis5vprevention5vof5vdisease5vby5valtering5vsusceptibility5vor5vreducing5vexposure5vfor5v
susceptible5vindividuals5vby5vproviding5vvaccination.5vSecondary5vprevention5vis5vthe5vearly5vdetection,5vsc
reening,5vand5vmanagement5vof5vthe5vdisease.5vTertiary5vprevention5vincludes5vrehabilitative5vand5vsupport
ive5vcare5vand
,attempts5vto5valleviate5vdisability5vand5vrestore5veffective5vfunctioning.5vDisease5vtreatment5vi
nvolves5vmanagement5vof5vthe5vdisease5vonce5vit5vhas5vdeveloped.
3. An5vobese5vbut5votherwise5vhealthy5vteen5vis5vgiven5va5vprescription5vfor5va5vlow-
calorie5vdiet5vand5vexercise5vprogram.5vThis5vis5van5vexample5vof
a. primary5vprevention.
b. secondary5vprevention.
c. tertiary5vprevention.
d. disease5vtreatmen
t.5vANS:5vB
Secondary5vprevention5vis5vthe5vearly5vdetection,5vscreening,5vand5vmanagement5vof5vthe5vdisease
5vsuch5vas5vprescribing5vdiet5vand5vexercise5vfor5van5vindividual5vwho5vhas5valready5vdeveloped5vobe
sity.
Primary5vprevention5vis5vprevention5vof5vdisease5vby5valtering5vsusceptibility5vor5vreducing5vexposure5vfor
5vsusceptible5vindividuals.5vTertiary5vprevention5vincludes5vrehabilitative5vand5vsupportive5vcare5vand5vatt
empts5vto5valleviate5vdisability5vand5vrestore5veffective5vfunctioning.5vDisease5vtreatment5vinvolves5vmana
gement5vof5vthe5vdisease5vonce5vit5vhas5vdeveloped.
4. A5vpatient5vwith5vhigh5vblood5vpressure5vwho5vis5votherwise5vhealthy5vis5vcounseled5vto5vrestri
ct5vsodium5vintake.5vThis5vis5van5vexample5vof
a. primary5vprevention.
b. secondary5vprevention.
c. tertiary5vprevention.
d. disease5vtreatmen
t.5vANS:5vB
Secondary5vprevention5vis5vthe5vearly5vdetection,5vscreening,5vand5vmanagement5vof5vthe5vdisease,5vsuch5
vas5vby5vprescribing5vsodium5vrestriction5vfor5vhigh5vblood5vpressure.5vPrimary5vprevention5vis5vprevention
5vof5vdisease5vby5valtering5vsusceptibility5vor5vreducing5vexposure5vfor5vsusceptible5vindividuals.5vTertiary5v
prevention5vincludes5vrehabilitative5vand5vsupportive5vcare5vand5vattempts5vto5valleviate5vdisability5vand5v
restore5veffective5vfunctioning.5vDisease5vtreatment5vinvolves5vmanagement5vof5vthe5vdisease5vonce5vit5vha
s5vdeveloped.
, 5. After5vsuffering5va5vheart5vattack,5va5vmiddle-
aged5vman5vis5vcounseled5vto5vtake5va5vcholesterol-lowering5vmedication.5vThis5vis5van5vexample5vof
a. primary5vprevention.
b. secondary5vprevention.
c. tertiary5vprevention.
d. disease5vtreatmen
t.5vANS:5vC
Tertiary5vprevention5vincludes5vrehabilitative5vand5vsupportive5vcare5vand5vattempts5vto5valleviate5vdisab
ility5vand5vrestore5veffective5vfunctioning5vsuch5vas5vprescribing5va5vcholesterol-lowering
medication5vfollowing5va5vheart5vattack.5vPrimary5vprevention5vis5vprevention5vof5vdisease5vby5valtering5
vsusceptibility5vor5vreducing5vexpUosuSre5vfNor5vsTusceptibOle5vindividuals.5vSecondary5vprevention5vis5
vthe
early5vdetection,5vscreening,5vand5vmanagement5vof5vthe5vdisease.5vDisease5vtreatment5vinvolves5vmanage
ment5vof5vthe5vdisease5vonce5vit5vhas5vdeveloped.
6. A5vpatient5vhas5vbeen5vexposed5vto5vmeningococcal5vmeningitis,5vbut5vis5vnot5vyet5vdemonstratin
g5vsigns5vof5vthis5vdisease.5vThis5vstage5vof5villness5vis5vcalled5vthe stage.
a. prodromal
b. latent
c. sequela
d. convalescence5
ANS:5vB
v
Incubation5vrefers5vto5vthe5vinterval5vbetween5vexposure5vof5va5vtissue5vto5van5vinjurious5vagent5vand5vthe5v
first5vappearance5vof5vsigns5vand5vsymptoms.5vIn5vinfectious5vdiseases,5vthis5vperiod5vis5voften5vcalled5vthe5v
incubation5v(latent)5vperiod.5vProdromal5vrefers5vto5vthe5vappearance5vof5vthe5vfirst5vsigns5vand5vsymptom
s5vindicating5vthe5vonset5vof5va5vdisease.5vThese5vare5voften5vnonspecific,5vsuch5vas5vheadache,5vmalaise,5van
orexia,5vand5vnausea,5vwhich5vare5vassociated5vwith5va5vnumber5vof5vdifferent5vdiseases.
Sequela5vrefers5vto5vsubsequent5vpathologic5vcondition5vresulting5vfrom5va5vdisease.5vConvalescence5vis5v
the5vstage5vof5vrecovery5vafter5va5vdisease,5vinjury,5vor5vsurgical5voperation.
7. A5vdisease5vthat5vis5vnative5vto5va5vparticular5vregion5vis5vcalled
a. epidemic.
b. endemic.
Pathophysiology 7th Edition
Jacquelyn L. Banasik - ISBN: 9780323761550
5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v5v
,Chapter5v01:5vIntroduction5vto5vPathophysiology
Banasik:5vPathophysiology,5v7th5vEdition5v
MULTIPLE5vCHOICE
1. C.Q.5vwas5vrecently5vexposed5vto5vgroup5vA5vhemolytic5vStreptococcus5vand5vsubsequently5vdev
eloped5va5vpharyngeal5vinfection.5vHis5vclinic5vexamination5vreveals5van5voral5vtemperature5vof5v102.35vF,5v
skin5vrash,5vdysphagia,5vand5vreddened5vthroat5vmucosa5vwith5vmultiple5vpustules.5vHe5vcomplains5vof5vs
ore5vthroat,5vmalaise,5vand5vjoint5vstiffness.5vA5vthroat5vculture5vis5vpositive5vfor5vStreptococcus,5vand5vant
ibiotics5vhave5vbeen5vprescribed.
The5vetiology5vof5vC.Q.’s5vdisease5vis
a. a5vsore5vthroat.
b. streptococcal5vinfection.
c. genetic5vsusceptibility.
d. pharyngitis.
ANS:5vB
Etiology5vrefers5vto5vthe5vproposed5vcause5vor5vcauses5vof5va5vparticular5vdisease5vprocess.5vA5vsore5vthr
oat5vis5vthe5vmanifestation5vof5vthe5vdisease5vprocess.5vGenetic5vsusceptibility5vrefers5vto5vinherited5vte
ndency5vto5vdevelop5va5vdisease.5vPharyngitis5vrefers5vto5vinflammation5vof5vthe5vthroat5vand5vis5valso5va5v
clinical5vmanifestation5vof5vthe5vdisease5vprocess.
2. A5v17-year-old5vcollege-
bound5vstudent5vreceives5va5vvaccine5vagainst5van5vorganism5vthat5vcauses5vmeningitis.5vThis5vis5van
5vexample5vof
a. primary5vprevention.
b. secondary5vprevention.
c. tertiary5vprevention.
d. disease5vtreatmen
t.5vANS:5vA
NURSINGTB.COM
Primary5vprevention5vis5vprevention5vof5vdisease5vby5valtering5vsusceptibility5vor5vreducing5vexposure5vfor5v
susceptible5vindividuals5vby5vproviding5vvaccination.5vSecondary5vprevention5vis5vthe5vearly5vdetection,5vsc
reening,5vand5vmanagement5vof5vthe5vdisease.5vTertiary5vprevention5vincludes5vrehabilitative5vand5vsupport
ive5vcare5vand
,attempts5vto5valleviate5vdisability5vand5vrestore5veffective5vfunctioning.5vDisease5vtreatment5vi
nvolves5vmanagement5vof5vthe5vdisease5vonce5vit5vhas5vdeveloped.
3. An5vobese5vbut5votherwise5vhealthy5vteen5vis5vgiven5va5vprescription5vfor5va5vlow-
calorie5vdiet5vand5vexercise5vprogram.5vThis5vis5van5vexample5vof
a. primary5vprevention.
b. secondary5vprevention.
c. tertiary5vprevention.
d. disease5vtreatmen
t.5vANS:5vB
Secondary5vprevention5vis5vthe5vearly5vdetection,5vscreening,5vand5vmanagement5vof5vthe5vdisease
5vsuch5vas5vprescribing5vdiet5vand5vexercise5vfor5van5vindividual5vwho5vhas5valready5vdeveloped5vobe
sity.
Primary5vprevention5vis5vprevention5vof5vdisease5vby5valtering5vsusceptibility5vor5vreducing5vexposure5vfor
5vsusceptible5vindividuals.5vTertiary5vprevention5vincludes5vrehabilitative5vand5vsupportive5vcare5vand5vatt
empts5vto5valleviate5vdisability5vand5vrestore5veffective5vfunctioning.5vDisease5vtreatment5vinvolves5vmana
gement5vof5vthe5vdisease5vonce5vit5vhas5vdeveloped.
4. A5vpatient5vwith5vhigh5vblood5vpressure5vwho5vis5votherwise5vhealthy5vis5vcounseled5vto5vrestri
ct5vsodium5vintake.5vThis5vis5van5vexample5vof
a. primary5vprevention.
b. secondary5vprevention.
c. tertiary5vprevention.
d. disease5vtreatmen
t.5vANS:5vB
Secondary5vprevention5vis5vthe5vearly5vdetection,5vscreening,5vand5vmanagement5vof5vthe5vdisease,5vsuch5
vas5vby5vprescribing5vsodium5vrestriction5vfor5vhigh5vblood5vpressure.5vPrimary5vprevention5vis5vprevention
5vof5vdisease5vby5valtering5vsusceptibility5vor5vreducing5vexposure5vfor5vsusceptible5vindividuals.5vTertiary5v
prevention5vincludes5vrehabilitative5vand5vsupportive5vcare5vand5vattempts5vto5valleviate5vdisability5vand5v
restore5veffective5vfunctioning.5vDisease5vtreatment5vinvolves5vmanagement5vof5vthe5vdisease5vonce5vit5vha
s5vdeveloped.
, 5. After5vsuffering5va5vheart5vattack,5va5vmiddle-
aged5vman5vis5vcounseled5vto5vtake5va5vcholesterol-lowering5vmedication.5vThis5vis5van5vexample5vof
a. primary5vprevention.
b. secondary5vprevention.
c. tertiary5vprevention.
d. disease5vtreatmen
t.5vANS:5vC
Tertiary5vprevention5vincludes5vrehabilitative5vand5vsupportive5vcare5vand5vattempts5vto5valleviate5vdisab
ility5vand5vrestore5veffective5vfunctioning5vsuch5vas5vprescribing5va5vcholesterol-lowering
medication5vfollowing5va5vheart5vattack.5vPrimary5vprevention5vis5vprevention5vof5vdisease5vby5valtering5
vsusceptibility5vor5vreducing5vexpUosuSre5vfNor5vsTusceptibOle5vindividuals.5vSecondary5vprevention5vis5
vthe
early5vdetection,5vscreening,5vand5vmanagement5vof5vthe5vdisease.5vDisease5vtreatment5vinvolves5vmanage
ment5vof5vthe5vdisease5vonce5vit5vhas5vdeveloped.
6. A5vpatient5vhas5vbeen5vexposed5vto5vmeningococcal5vmeningitis,5vbut5vis5vnot5vyet5vdemonstratin
g5vsigns5vof5vthis5vdisease.5vThis5vstage5vof5villness5vis5vcalled5vthe stage.
a. prodromal
b. latent
c. sequela
d. convalescence5
ANS:5vB
v
Incubation5vrefers5vto5vthe5vinterval5vbetween5vexposure5vof5va5vtissue5vto5van5vinjurious5vagent5vand5vthe5v
first5vappearance5vof5vsigns5vand5vsymptoms.5vIn5vinfectious5vdiseases,5vthis5vperiod5vis5voften5vcalled5vthe5v
incubation5v(latent)5vperiod.5vProdromal5vrefers5vto5vthe5vappearance5vof5vthe5vfirst5vsigns5vand5vsymptom
s5vindicating5vthe5vonset5vof5va5vdisease.5vThese5vare5voften5vnonspecific,5vsuch5vas5vheadache,5vmalaise,5van
orexia,5vand5vnausea,5vwhich5vare5vassociated5vwith5va5vnumber5vof5vdifferent5vdiseases.
Sequela5vrefers5vto5vsubsequent5vpathologic5vcondition5vresulting5vfrom5va5vdisease.5vConvalescence5vis5v
the5vstage5vof5vrecovery5vafter5va5vdisease,5vinjury,5vor5vsurgical5voperation.
7. A5vdisease5vthat5vis5vnative5vto5va5vparticular5vregion5vis5vcalled
a. epidemic.
b. endemic.
